Dilazep
From Wikipedia, the free encyclopedia
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | C01DX10 (WHO) |
Identifiers | |
|
|
PubChem (CID) | 3074 |
IUPHAR/BPS | 4717 |
ChemSpider | 2965 |
UNII | F8KLC2BD5Z |
KEGG | D07843 |
ChEMBL | CHEMBL126075 |
Chemical and physical data | |
Formula | C31H44N2O10 |
Molar mass | 604.69 g/mol |
3D model (Jmol) | Interactive image |
|
|
|
|
(verify) |
Dilazep is a vasodilator that acts as an adenosine reuptake inhibitor.[1]
See also[edit]
- Hexobendine, a drug with similar chemical structure
References[edit]
- ^ Hiroshi Deguchi; Hiroyuki Takeya; Hideo Wada; Esteban C. Gabazza; Nobuyuki Hayashi; Hajime Urano; Koji Suzuki (September 15, 1997). "Dilazep, an Antiplatelet Agent, Inhibits Tissue Factor Expression in Endothelial Cells and Monocytes". Blood. 90: 2345–2356.
This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |